dexmedetomidin
dexmedetomidin is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dexmedetomidine vs Propofol in High-Risk ERCP Patients
Post Operative Shivering Following Anesthesia
Role of Pericapsular Nerve Block Using Dexmedetomidine and Bupivacaine in Improving the Outcome of Patients Undergoing Hip Surgery Under Spinal Anesthesia
Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy
Postoperative Cognitive Dysfunction in Transsphenoidal Pituitary Surgeries
Clinical Trials (9)
Dexmedetomidine vs Propofol in High-Risk ERCP Patients
Post Operative Shivering Following Anesthesia
Role of Pericapsular Nerve Block Using Dexmedetomidine and Bupivacaine in Improving the Outcome of Patients Undergoing Hip Surgery Under Spinal Anesthesia
Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy
Postoperative Cognitive Dysfunction in Transsphenoidal Pituitary Surgeries
Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
Comparison of the Effects of Dexmedetomidine and Propofol on the Cardiovascular Autonomic Nervous System During Spinal Anesthesia
Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block
Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9